Epithelial cell polarity and tumorigenesis: New perspectives for cancer detection and treatment

Acta Pharmacologica Sinica

Volumn 32, Issue 5, 2011, Pages 552-564

  Coradini, Danila ^a   Casarsa, Claudia ^b   Oriana, Saro ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c Senology Center   (Italy)

Author keywords

cell polarity; differential diagnosis; epithelial tumors

Indexed keywords

ALPHA CATENIN; ATYPICAL PROTEIN KINASE; BETA CATENIN; CLAUDIN; CLOSTRIDIUM PERFRINGENS ENTEROTOXIN; ENTEROTOXIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; F ACTIN; HISTONE DEACETYLASE INHIBITOR; MEMBRANE ASSOCIATED GUANYLATE CYCLASE KINASE; MEMBRANE PROTEIN; MONOCLONAL ANTIBODY; NECTIN 1; NERVE CELL ADHESION MOLECULE; OCCLUDIN; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLAKOGLOBIN; POSTSYNAPTIC DENSITY PROTEIN 95; PROTEIN CDC42; PROTEIN P120; PROTEIN ZO1; PROTEIN ZO2; RAC1 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; TRICELLULIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; UVOMORULIN; VON HIPPEL LINDAU PROTEIN; WNT PROTEIN;

ADVANCED CANCER; AMINO TERMINAL SEQUENCE; BASEMENT MEMBRANE; BREAST ADENOCARCINOMA; CAENORHABDITIS ELEGANS; CANCER DIAGNOSIS; CANCER GRADING; CANCER GROWTH; CANCER IMMUNOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CANCER THERAPY; CARCINOGENESIS; CELL DIFFERENTIATION; CELL LEVEL; CELL MEMBRANE DEPOLARIZATION; CELL POLARITY; CELL PROLIFERATION; CELL STRUCTURE; CELLULAR DISTRIBUTION; CLEAR CELL CARCINOMA; CLEAR CELL RENAL CARCINOMA; COLON ADENOCARCINOMA; CYTOLYSIS; CYTOSKELETON; DISEASE ASSOCIATION; DOWN REGULATION; DROSOPHILA MELANOGASTER; ELECTRON MICROSCOPY; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE SILENCING; GENETIC REGULATION; GENETIC TRANSCRIPTION; GLEASON SCORE; HEMANGIOBLASTOMA; HETEROZYGOSITY; HUMAN; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SPACE; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT PLEURAL MESOTHELIOMA; MESENCHYME CELL; METASTASIS; MOLECULARLY TARGETED THERAPY; MOUTH CARCINOMA; NONHUMAN; ORAL SQUAMOUS CELL CARCINOMA; OVARY CANCER; PANCREAS CANCER; PARANEOPLASTIC SYNDROME; PDZ DOMAIN; PLEURA MESOTHELIOMA; PROGNOSIS; PROTEIN BINDING; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SQUAMOUS CELL CARCINOMA; THYROID PAPILLARY CARCINOMA; TIGHT JUNCTION; UTERINE CERVIX CARCINOMA; WART VIRUS;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION; CELL POLARITY; DRUG DELIVERY SYSTEMS; EPITHELIAL CELLS; HUMANS; INTERCELLULAR JUNCTIONS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS; PROGNOSIS;

EID: 79959724248     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1038/aps.2011.20     Document Type: Review

References (154)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer Statistics, 2008. CA Cancer J Clin 2008; 58: 71-96.
2. Thiery JP. Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer 2002; 2: 442-4.
3. Thompson EW, Newgreen DF. Carcinoma invasion and metastasis: a role for epithelial-mesenchymal transition? Cancer Res 2005; 65: 5991-5.
4. Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139: 871-90.
5. Micalizzi DS, Ford HL. Epithelial-mesenchymal transition in development and cancer. Future Oncol 2009; 5: 1129-43.
6. Radisky DC. Epithelial-mesenchymal transition. J Cell Sci 2005; 118: 4325-6.
7. Zavadil J, Haley J, Kalluri R, Muthuswamy SK, Thompson E. Epithelial-mesenchymal transition. Cancer Res 2008; 68: 9574-7.
8. Lee M, Vasioukhin V. Cell polarity and cancer-cell and tissue polarity as a non-canonical tumor suppressor. J Cell Sci 2008; 121: 1141-50. (Pubitemid 351753497)
9. Hugo H, Ackland ML, Blick T, Lawrence MG, Clemens JA, Williams ED, et al. Epithelial-mesenchymal and mesenchymal-epithelial transitions in carcinoma progression. J Cell Physiol 2007; 213: 374-83. (Pubitemid 47509716)
10. Moreno-Buono G, Portillo F, Cano A. Transcriptional regulation of cell polarity in EMT and cancer. Oncogene 2008; 27: 6958-69.
11. Cavallaro U, Christofori G. Cell adhesion and signalling by cadherins and Ig-CAMs in cancer. Nat Rev Cancer 2004; 4: 118-32. (Pubitemid 38198740)
12. Cowin P, Rowlands TM, Hatsell SJ. Cadherins and catenins in breast cancer. Curr Opin Cell Biol 2005; 17: 499-5.
13. Dow LE, Humbert PO. Polarity regulators and the control of epithelial architecture, cell migration, and tumorigenesis. Int Rev Cytol 2007; 262: 253-302. (Pubitemid 47031311)
14. Tanos B, Rodriguez-Boulan E. The epithelial polarity program: machineries involved and their hijacking by cancer. Oncogene 2008; 27: 6939-57.
15. Niessen CM. Tight junctions/adherens junctions: basic structure and function. J Invest Dermatol 2007; 127: 2525-32. (Pubitemid 47585053)
16. Hartsock A, Nelson WJ. Adherens and tight junctions: structure, function and connections to the actin cytoskeleton. Biochim Biophys Acta 2008; 1778: 660-9. (Pubitemid 351317795)
17. Matter K, Balda MS. Epithelial tight junctions, gene expression and nucleojunctional interplay. J Cell Sci 2007; 120: 1505-11. (Pubitemid 46831780)
18. Matter K, Aijaz S, Tsapara A, Balda MS. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr Opin Cell Biol 2005; 17: 453-8. (Pubitemid 41267158)
19. Schneeberger EE, Lynch RD. The tight junction: a multifunctional complex. Am J Physiol Cell Physiol 2004; 286: C1213-28.
20. Harris TJC, Tepass U. Adherens junctions: from molecules to morphogenesis. Nature Rev Mol Cell Biol 2010; 11: 502-4.
21. Morita K, Furuse M, Fujimoto K, Tsukita S. Claudin multigene family encoding four-transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A 1999; 96: 511-6. (Pubitemid 29061239)
22. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, et al. Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 1993; 123: 1777-88. (Pubitemid 24012933)
23. Ikenouchi M, Furuse K, Furuse H, Sasaki S, Tsukita S. Tricellulin constitutes a novel barrier at tricellular contacts of epithelial cells. J Cell Biol 2005; 171: 939-45. (Pubitemid 41815826)
24. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, Pochet M, et al. Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 2000; 113: 2363-74. (Pubitemid 30599341)
25. Krause G, Winkler L, Mueller SL, Haseloff RF, Piontek J, Blasig IE. Structure and function of claudins. Biochim Biophys Acta 2008; 1778: 631-45.
26. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002; 156: 1099-111. (Pubitemid 34839858)
27. Sasaki H, Matsui C, Furuse K, Mimori-Kiyosue Y, Furuse M, Tsukita S. Dymanic behaviour of paired claudin strands within opposing plasma membranes. Proc Natl Acad Sci U S A 2003; 100; 3971-76. (Pubitemid 36418141)
28. Rehder D, Iden S, Nasdala I, Wegener J, Brickwedde MK, Vestweber D, et al. Junctional adhesion molecule-A participates in the formation of apico-basal polarity through different domains. Exp Cell Res 2006; 312: 3389-403. (Pubitemid 44380238)
29. Citi S, Amorosi A, Franconi F, Giotti A, Zampi G. Cingulin, a specific protein component of tight junctions, is expressed in normal and neoplastic human epithelial tissues. Am J Pathol 1991; 138: 781-9.
30. Keon BH, Schifer S, Kuhn C, Grund C, Franke WW. Symplekin, a novel type of tight junction plaque protein. J Cell Biol 1996; 134: 1003-18. (Pubitemid 26278224)
31. Nishimura M, Kakizaki M, Ono Y, Morimoto K, Takeuchi M, Inoue Y, et al. JEAP, a novel component of tight junctions in exocrine cells. J Biol Chem 2002; 277: 5583-7. (Pubitemid 34968611)
32. Fanning AS, Anderson JM. Zonula occludens-1 and -2 are cytosolic scaffolds that regulate the assembly of cellular junctions. Ann NY Acad Sci 2009; 1165: 113-20.
33. Straight SW, Shin K, Fogg VC, Fan S, Liu C-J, Roh M, et al. Loss of PALS1 expression leads to tight junction and polarity defects. Mol Biol Cell 2004; 15: 1981-90. (Pubitemid 38401844)
34. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S. Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 1999; 147: 1351-63. (Pubitemid 30012818)
35. Ide N, Hata Y, Nishioka H, Hirao K, Yao I, Deguchi M, et al. Localization of membrane-associated guanylate kinase (MAGI)-1/BAI-associated protein (BAP) 1 at tight junctions of epithelial cells. Oncogene 1999; 18: 7810-5. (Pubitemid 30052766)
36. Thomas M, Laura R, Hepner K, Guccione E, Sawyers C, Lasky L, et al. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 2002; 21: 5088-96.
37. Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, et al. Interaction of the tumor suppressor PTEN/MMAC with a PDZ Domain of MAGI3, a novel membrane-associated guanylate kinase. J Biol Chem 2000; 275: 21477-85. (Pubitemid 30481851)
38. Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan XJ, et al. Evidence for regulation of the PTEN tumor suppressor by a membrane-localized multi-PDZ domain containing scaffold protein MAGI-2. Proc Natl Acad Sci U S A 2000; 97: 4233-8. (Pubitemid 30226116)
39. Shin K, Straight S, Margolis B. PATJ regulates tight junction formation and polarity in mammalian epithelial cells. J Cell Biol 2005; 168: 705-11. (Pubitemid 40328155)
40. Adachi M, Hamazaki Y, Kobayashi Y, Itoh M, Tsukita S, Furuse M, et al. Similar and distinct properties of MUPP1 and Patj, two homologous PDZ domain-containing tight-junction proteins. Mol Cell Biol 2009; 29: 2372-89.
41. Goodwin M, Yap AS. Classical cadherin adhesion molecules: coordinating cell adhesion, signaling and the cytoskeleton. J Mol Histol 2004; 35: 839-44. (Pubitemid 41404630)
42. Kobielak A, Fuchs E. α-Catenin: at the junction of intercellular adhesion and actin dynamics. Nat Rev Mol Cell Biol 2004; 5: 614-25. (Pubitemid 39025062)
43. Xu W, Kimelman D. Mechanistic insights from structural studies of β-catenin and its binding partners. J Cell Sci 2007; 120: 3337-44. (Pubitemid 350028341)
44. Reynolds AB. p120-catenin: Past and present. Biochim Biophys Acta 2007; 1773: 2-7.
45. Chen Y T, Stewart DB, Nelson WJ. Coupling Assembly of the E-cadherin/β-catenin complex to efficient endoplasmic reticulum exit and basal-lateral membrane targeting of E-cadherin in polarized MDCK cells. J Cell Biol 1999; 144: 687-99. (Pubitemid 29234547)
46. Bajpai S, Correia J, Feng Y, Figueiredo J, Sun SX, Longmore GD, et al. α-Catenin mediates initial E-cadherin-dependent cell-cell recognition and subsequent bond strengthening. Proc Natl Acad Sci U S A 2008; 105: 18331-6.
47. Ireton RC, Davis MA, van Hengel J, Mariner DJ, Barnes K, Thoreson MA, et al. A novel role for p120 catenin in E-cadherin function. J Cell Biol 2002; 159: 465-76. (Pubitemid 35332833)
48. Tachibana K, Nakanishi H, Mandai K, Ozaki K, Ikeda W, Yamamoto Y, et al. Two cell adhesion molecules, nectin and cadherin, interact through their cytoplasmic domain-associated proteins. J Cell Biol 2000; 150: 1161-76.
49. Takai Y, Ikeda W, Ogita H, Rikitake Y. The immunoglobulin-like cell adhesion molecule nectin and its associated protein afadin. Annu Rev Cell Dev Biol 2008; 24: 309-42.
50. Takai Y, Irie K, Shimizu K, Sakisaka T, Ikeda W. Nectins and nectin-like molecules: roles in cell adhesion, migration, and polarization. Cancer Sci 2003; 94: 655-67. (Pubitemid 37160921)
51. Irie K, Shimizu K, Sakisaka T, Ikeda W, Takai Y. Roles and modes of action of nectins in cell-cell adhesion. Semin Cell Dev Biol 2004; 15: 643-56. (Pubitemid 39550244)
52. Cereijido M, Contreras RG, Shoshani L, Flores-Benitez D, Larre I. Tight junction and polarity interaction in the transporting epithelial phenotype. Biochim Biophys Acta 2008; 1778: 770-93. (Pubitemid 351317802)
53. Humbert PO, Down LE, Russell SM. The scribble and Par complexes in polarity and migration: friends or foes? Trends Cell Biol 2006; 16: 622-30.
54. Assemat E, Bazellieres E, Pallesi-Pocachard E, Le Bivic A, Massey- Harroche D. Polarity complex proteins. Biochim Biophys Acta 2008; 1778: 614-30. (Pubitemid 351317801)
55. Suzuki A, Ohno S. The PAR-aPKC system: lessons in polarity. J Cell Sci 2006; 119: 979-87.
56. Kemphues KJ, Priess JR, Mortn DG, Cheng NS. Identification of genes required for cytoplasmic localization in early C elegans embryos. Cell 1988; 52: 311-20.
57. Goldstein B, Macara IG. The PAR proteins: fundamental players in animal cell polarization. Dev Cell 2007; 13: 609-22. (Pubitemid 350011991)
58. Lemmers C, Medina E, Delgrossi MH, Michel D, Arsanto JP, Le Bivic A. hINADL/PATJ, a homolog of discs lost, interacts with crumbs and localizes to tight junctions in human epithelial cells. J Biol Chem 2002; 277: 25408-15. (Pubitemid 34951853)
59. Michel D, Arsanto JP, Massey-Harroche D, Béclin C, Wijnholds J, Le Bivic A. PATJ connects and stabilizes apical and lateral components of tight junctions in human intestinal cells. J Cell Sci 2005; 118: 4049-57. (Pubitemid 41410286)
60. Dow LE, Brumby AM, Muratore R, Coombe ML, Sedelies KA, Trapani JA, et al. hScrib is a functional homologue of the Drosophila tumour suppressor Scribble. Oncogene 2003; 22: 9225-30. (Pubitemid 38122034)
61. Yamanaka T, Ohno S. Role of Lgl/Dlg/Scribble in the regulation of epithelial junction, polarity and growth. Front Biosci 2008; 13: 6693-6707.
62. Itoh M, Sasaki H, Furuse M, Ozaki H, Kita T, Tsukita S. Junctional adhesion molecule (JAM) binds to PAR-3: a possible mechanism for the recruitment of PAR-3 to tight junctions. J Cell Biol 2001; 154: 491-7. (Pubitemid 34286156)
63. Schock F, Perrimon N. Molecular mechanisms of epithelial morphogenesis. Annu Rev Cell Dev Biol 2002; 18: 463-93. (Pubitemid 35387358)
64. Gibson MC, Perrimon N. Apicobasal polarization: epithelial form and function. Curr Opin Cell Biol 2003; 15: 747-52. (Pubitemid 37487968)
65. Clevers H. Wnt/β-catenin signaling in development and disease. Cell 2007; 127: 469-80.
66. Gottardi CJ, Arpin M, Fanning AS, Louvard D. The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts. Proc Natl Acad Sci U S A 1996; 93: 10779-84. (Pubitemid 26333066)
67. Traweger A, Fuchs R, Krizbai IA, Weiger TM, Bauer HC, Bauer H. The tight junction protein zo-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-B. J Biol Chem 2003; 278: 2692-700. (Pubitemid 36801350)
68. Fang L, Wang Y, Du D, Yang G, Tak Kwok T, Kai Kong S, et al. Cell polarity protein Par3 complexes with DNA-PK via Ku70 and regulates DNA double-strand break repair. Cell Res 2007; 17: 100-16. (Pubitemid 46279234)
69. Cline EG, Nelson WJ. Characterization of mammalian Par 6 as a dual-location protein. Mol Cell Biol 2007; 27: 4431-43. (Pubitemid 46906566)
70. Garcia-Mata R, Dubash AD, Sharek L, Carr HS, Frost JA, Burridge K. The nuclear RhoA exchange factor Net1 interacts with proteins of the Dlg family, affects their localization and influences their tumor suppressor activity. Mol Cell Biol 2007; 27: 8683-97.
71. Chandramouly G, Abad PC, Knowles DW, Lelièvre SA. The control of tissue architecture over nuclear organization is crucial for epithelial cell fate. J Cell Sci 2007; 120: 1596-1606. (Pubitemid 46831789)
72. Traweger A, Lehner C, Farkas A, Krizbai IA, Tempfer H, Klement E, et al. Nuclear Zonula occludens-2 alters gene expression and junctional stability in epithelial and endothelial cells. Differentiation 2008; 76: 99-106.
73. Lelièvre SA. Tissue polarity-dependent control of mammary epithelial homeostasis and cancer development: an epigenetic perspective. J Mammary Gland Biol Neoplasia 2010; 15: 49-63.
74. Buchert M, Papin M, Bonnans C, Darido C, Raye WS, Garambois V, et al. Symplekin promotes tumorigenicity by up-regulating claudin-2 expression. Proc Natl Acad Sci U S A 2010; 107: 2628-33.
75. Thiery J. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003; 15: 740-6. (Pubitemid 37487967)
76. Gupta A, Massaguè J. Cancer metastasis: building a framework. Cell 2006; 127: 679-95. (Pubitemid 44781029)
77. Hoover KB, Liao S-Y, Bryant PJ. Loss of the tight junction MAGUK ZO-1 in breast cancer: relationship to glandular differentiation and loss of heterozygosity. Am J Pathol 1998; 153: 1767-73. (Pubitemid 28550664)
78. Soler AP, Miller RD, Laughlin KV, Carp NZ, Klurfed DM, Mullin JM. Increased tight junctional permeability is associated with the development of colon cancer. Carcinogenesis 1999; 20: 1425-31. (Pubitemid 29385425)
79. Tobioka H, Isomura H, Kokai Y, Tokunaga Y, Yamaguchi J, Sawada N. Occludin expression decreases with the progression of human endometrial carcinoma. Hum Pathol 2004; 35: 159-64. (Pubitemid 38240897)
80. Macarthur M, Hold GL, El-Omar EM. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 2004; 286: G515-20.
81. Javier RT. Cell polarity proteins: common targets for tumorigenic human viruses. Oncogene 2008; 27: 7031-46.
82. Polette M, Gilles C, Nawrocki-Raby B, Lohi J, Hunziker W, Foidart JM, et al. Membrane-type 1 matrix metalloproteinase expression is regulated by zonula occludens-1 in human breast cancer cells. Cancer Res 2005; 65: 7691-8. (Pubitemid 41297243)
83. Brembeck FH, Rosario M, Birchmeier W. Balancing cell adhesion and Wnt signaling, the key role of β-catenin. Curr Opin Genet Dev 2006; 16: 51-9. (Pubitemid 43089612)
84. Huber M, Kraut N, Beug H. Molecular requirements for epithelial- mesenchymal transition during tumor progression. Curr Opin Cell Biol 2005; 17: 548-58. (Pubitemid 41267170)
85. Thiery J, Sleeman J. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7: 131-42. (Pubitemid 43278296)
86. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nature Rev Cancer 2007; 7: 415-28.
87. Wheelock MJ, Shintani Y, Maeda M, Fukumoto Y, Johnson KR. Cadherin switching. J Cell Sci 2008; 121: 727-35. (Pubitemid 351578108)
88. Storrs CH, Silverstein SJ. PATJ, a tight junction-associated PDZ protein, is a novel degradation target of high-risk human papillomavirus E6 and the alternatively spliced isoform 18 E6. J Virol 2007; 81: 4080-90. (Pubitemid 46586903)
89. Thomas M, Glaunsinger B, Pim D, Javier R, Banks L. HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene 2001; 20: 5431-9. (Pubitemid 32889479)
90. Nakagawa S, Huibregtse JM. Human scribble (vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus e6 proteins and the e6ap ubiquitin-protein ligase. Mol Cell Biol 2000; 20: 8244-53.
91. Gardiol D, Kuhne C, Glaunsinger B, Lee SS, Javier R, Banks L. Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation. Oncogene 1999; 18: 5487-96. (Pubitemid 29481495)
92. Gateff E. Malignant neoplasms of genetic origin in Drosophila melanogaster. Science 1978; 200: 1448-59. (Pubitemid 8386753)
93. Bilder D. Epithelial polarity and proliferation control: links from Drosophila neoplastic tumor suppressors. Genes Dev 2004; 18: 1909-25. (Pubitemid 39071572)
94. Klezovitch O, Fernandez TE, Tapscott SJ, Vasioukhin V. Loss of cell polarity causes severe brain dysplasia in Lgl1 knockout mice. Genes Dev 2004; 18: 559-71. (Pubitemid 38372812)
95. Lisovsky M, Dresser K, Baker S, Fisher A, Woda B, Banner B, et al. Cell polarity protein Lgl2 is lost or aberrantly localized in gastric dysplasia and adenocarcinoma: an immunohistochemical study. Mod Pathol 2009; 22: 977-84.
96. Massimi P, Narayan N, Cuenda A, Banks L. Phosphorylation of the disc large tumor suppressor protein controls its membrane localization and enhances its susceptibility to HPV E6-induced degradation. Oncogene 2006; 25: 4276-85. (Pubitemid 44100498)
97. Latorre IJ, Roh MH, Frese KK, Weiss RS, Margolis B, Javier RT. Viral oncoprotein-induced mislocalization of select PDZ proteins disrupts tight junctions and causes polarity defects in epithelial cells. J Cell Sci 2005; 118: 4283-93. (Pubitemid 41488965)
98. Karp CM, Tan TT, Mathew R, Nelson D, Mukherjee C, Degenhardt K, et al. Role of the polarity determinant crumbs in suppressing mammalian epithelial tumor progression. Cancer Res 2008; 68: 4105-15.
99. Eder AM, Sui X, Rosen DG, Nolden LK, Cheng KW, Lahad JP, et al. Atypical PKCi contributes to poor prognosis through loss of apical- basal polarity and Cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci U S A 2005; 102: 12519-24. (Pubitemid 41266391)
100. Murray NR, Jamieson L, Yu W, Zhang J, Gokmen-Polar Y, Sier D. Protein kinase Ciota is required for Ras transformation and colon carcinogenesis in vivo. J Cell Biol 2004; 164: 797-802. (Pubitemid 38366891)
101. Regala RP, Weems C, Jamieson L, Copland JA, Thompson EA, Fields AP. Atypical protein kinase Ciota plays a critical role in human lung cancer cell growth and tumorigenicity. J Biol Chem 2005; 280: 31109-15. (Pubitemid 41291846)
102. Aranda V, Nolan ME, Muthuswamy SK. Par complex in cancer: a regulator of normal polarity joins the dark side. Oncogene 2008; 27: 6878-87.
103. Aranda V, Haire T, Nolan ME, Calarco JP, Rosenberg AZ, Fawcett JP, et al. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nature Cell Biol 2006; 8: 1235-48.
104. Wang X, Nie J, Zhou Q, Liu W, Zhu F, Chen W, et al. Downregulation of Par-3 expression and disruption of Par complex integrity by TGFbeta during the process of epithelial to mesenchymal transition in rat proximal epithelial cells. Biochim Biophys Acta 2008; 1782: 51-9.
105. Okuda H, Saitoh K, Hirai S, Iwai K, Takaki Y, Baba M, et al. The von Hippel-Lindau tumor suppressor protein mediates ubiquitination of activated atypical protein kinase C. J Biol Chem 2001; 276: 43611-7.
106. Graziano F, Humar B, Guilford P. The role of E-cadherin gene (CDH1) in diffuse gastric cancer susceptibility: from the laboratory to clinical practice. Ann Oncol 2003; 14: 1705-13. (Pubitemid 38029040)
107. Perl AK, Wilgenbus P, Dahl U, Semb H, Christofori G. A causal role for E-cadherin in the transition from adenoma to carcinoma. Nature 1998; 392: 190-3. (Pubitemid 28162793)
108. Ohtani S, Terashima M, Satoh J, Soeta N, Saze Z, Kashimura S, et al. Expression of tight-junction-associated proteins in human gastric cancer: down-regulation of claudin-4 correlates with tumor aggressiveness and survival. Gastric Cancer 2009; 12: 43-51.
109. Martin TA, Mansel RE, Jiang WG. Loss of occludin leads to the progression of human breast cancer. Int J Mol Med 2010; 26: 723-34.
110. Busch C, Hanssen TA, Wagener C, O'Brink B. Down-regulation of CEACAM1 in human prostate cancer: correlation with loss of cell polarity, increased proliferation rate, and Gleason grade 3 to 4 transition. Hum Pathol 2002; 33: 290-8. (Pubitemid 34461462)
111. Sheehan GM, Kallakury BVS, Sheehan CE, Fisher HAG, Kaufman RP, Ross JS. Loss of claudins-1 and -7 and expression of claudins-3 and -4 correlate with prognostic variables in prostatic adenocarcinomas. Hum Pathol 2007; 38: 564-9. (Pubitemid 46399893)
112. Tokés AM, Kulka J, Paku S, Szik A, Páska C, Novák PK, et al. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study. Breast Cancer Res 2005; 7: R296-305.
113. Cohn ML, Goncharuk VN, Diwan AH, Zhang PS, Shen SS, Prieto VG. Loss of claudin-1 expression in tumor-associated vessels correlates with acquisition of metastatic phenotype in melanocytic neoplasms. J Cutaneous Pathol 2005; 32: 533-6. (Pubitemid 41224420)
114. Miyamoto K, Kusumi T, Sato F, Kawasaki H, Shibata S, Ohashi M, et al. Decreased expression of claudin-1 is correlated with recurrence status in esophageal squamous cell carcinoma. Biomed Res 2008; 29: 71-6. (Pubitemid 351753465)
115. Chao YC, Pan SH, Yang SC, Yu SL, Che TF, Lin CW, et al. Claudin-1 is a metastatic suppressor and correlates with clinical outcome in lung adenocarcinoma. Am J Resp Crit Care Med 2009; 179: 123-33.
116. Nemeth J, Nemeth Z, Tatrai P, Peter I, Somoracz A, Szasz AM, et al. High expression of claudin-1 protein in papillary thyroid tumor and its regional lymph node metastasis. Pathol Oncol Res 2010;16: 19-27.
117. Oku N, Sasabe E, Ueta E, Yamamoto T, Osaki T. Tight junction protein claudin-1 enhances the invasive activity of oral squamous cell carcinoma cells by promoting cleavage of laminin-5 gamma2 chain via matrix metalloproteinase (MMP)-2 and membrane-type MMP-1. Cancer Res 2006; 66: 5251-7. (Pubitemid 43844949)
118. Kleinberg L, Holth A, Trope CG, Reich R, Davidson B. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival. Hum Pathol 2008; 39: 747-57. (Pubitemid 351618309)
119. Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, et al. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res 2007; 27: 3729-34. (Pubitemid 47598437)
120. Leotlela PD, Wade MS, Duray PH, Rhode MJ, Brown HF, Rosenthal DT, et al. Claudin-1 overexpression in melanoma is regulated by PKC and contributes to melanoma cell motility. Oncogene 2007; 26: 3846-56. (Pubitemid 46880988)
121. Wu YL, Zhang S, Wang GR, Chen YP. Expression transformation of claudin-1 in the process of gastric adenocarcinoma invasion. World J Gastroenterol 2008; 14: 4943-8.
122. Nemeth Z, Szasz AM, Somoracz A, Tatrai P, Nemeth J, Gyorffy H, et al. Zonula occludens-1, occludin, and E-cadherin protein expression in biliary tract cancers. Pathol Oncol Res 2009; 15: 533-9.
123. Gutwein P, Schramme A, Voss B, Abdel-Bakky MS, Doberstein K, Ludwig A, et al. Downregulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma. Biochem Biophys Res Commun 2009; 380: 387-91.
124. Koshiba H, Hosokawa K, Kubo A, Tokumitsu N, Watanabe A, Honjo H. Junctional adhesion molecule A expression in human endometrial carcinoma. Int J Gynecol Cancer 2009; 19: 208-13.
125. Smalley KS, Brafford P, Haass NK, Brandner JM, Brown E, Herlyn M. Up-regulated expression of zonula occludens protein-1 in human melanoma associates with N-cadherin and contributes to invasion and adhesion. Am J Pathol 2005; 166: 1541-54. (Pubitemid 40586522)
126. Kleeff J, Shi X, Bode HP, Hoover K, Shrikhande S, Bryant PJ, et al. Altered expression and localization of the tight junction protein ZO-1 in primary and metastatic pancreatic cancer. Pancreas 2001; 23: 259-65. (Pubitemid 32910974)
127. McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, et al. JAM-A expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer 2009; 125: 1343-51.
128. Takagawa R, Akimoto K, Ichikawa Y, Akiyama H, Kojima Y, Ishiguro H, et al. High expression of atypical protein kinase C lambda/iota in gastric cancer as a prognostic factor for recurrence. Ann Surg Oncol 2010; 17: 81-8.
129. Lisovsky M, Ogawa F, Dresser K, Woda B, Lauwers GY. Loss of cell polarity protein Lgl2 in foveolar-type gastric dysplasia: correlation with expression of the apical marker aPKC-zeta. Virchows Arch 2010; 457: 635-42.
130. Lisovsky M, Dresser K, Woda B, Mino-Kenudson M. Immunohistochemistry for cell polarity protein lethal giant larvae 2 differentiates pancreatic intraepithelial neoplasia-3 and ductal adenocarcinoma of the pancreas from lower-grade pancreatic intraepithelial neoplasias. Hum Pathol 2010; 41: 902-9.
131. Grifoni D, Garoia F, Schimanski CC, Schmitz G, Laurenti E, Galle PR, et al. The human protein Hugl-1 substitutes for Drosophila Lethal giant larvae tumour suppressor function in vivo. Oncogene 2004; 23: 8688-94. (Pubitemid 39576476)
132. Kuphal S, Wallner S, Schimanski CC, Bataille F, Hofer P, Strand S, et al. Expression of Hugl-1 is strongly reduced in malignant melanoma. Oncogene 2006; 25: 103-10. (Pubitemid 43050008)
133. Schimanski CC, Schmitz G, Kashyap A, Bosserhoff AK, Bataille F, Schafer SC, et al. Reduced expression of Hugl-1, the human homologue of Drosophila tumour suppressor gene lgl, contributes to progression of colorectal cancer. Oncogene 2005; 24: 3100-9. (Pubitemid 40695079)
134. Lu X, Feng X, Man X, Yang G, Tang L, Du D, et al. Splicing of Hugl-1 is associated with hepatocellular carcinoma progression. Clin Cancer Res 2009; 15: 3287-96.
135. Lin HT, Steller MA, Aish L, Hanada T, Chishti AH. Differential expression of human Dlg in cervical intraepithelial neoplasias. Gynecol Oncol 2004; 93: 422-8. (Pubitemid 38507612)
136. Cavatorta AL, Fumero G, Choihy D, Aguirre R, Nocito AL, Giri AA, et al. Differential expression of the human homologue of Drosophila discs large oncosuppressor in histologic samples from human papillomavirus-associated lesions as a marker for progression to malignancy. Int J Cancer 2004; 111: 373-80. (Pubitemid 38998817)
137. Gardiol D, Zacchi A, Petrera F, Stanta G, Banks L. Human discs large and scrib are localized at the same regions in colon mucosa and changes in their expression patterns are correlated with loss of tissue architecture during malignant progression. Int J Cancer 2006; 119: 1285-90. (Pubitemid 44258801)
138. Ouyang Z, Zhan W, Dan L. hScrib, a human homolog of Drosophila neoplastic tumor suppressor, is involved in the progress of endometrial cancer. Oncol Res 2010; 18: 593-9.
139. Nakagawa S, Yano T, Nakagawa K, Takizawa S, Suzuki Y, Yasugi T, et al. Analysis of the expression and localisation of a LAP protein, human scribble, in the normal and neoplastic epithelium of uterine cervix. Br J Cancer 2004; 90: 194-9. (Pubitemid 38174961)
140. Kamei Y, Kito K, Takeuchi T, Imai Y, Murase R, Ueda N, et al. Human scribble accumulates in colorectal neoplasia in association with an altered distribution of beta-catenin. Hum Pathol 2007; 38: 1273-81. (Pubitemid 47058166)
141. Nolan ME, Aranda V, Lee S, Lakshmi B, Basu S, Allred DC, et al. The polarity protein par6 induces cell proliferation and is overexpressed in breast cancer. Cancer Res 2008; 68: 8201-9.
142. Casarsa C, Bassani N, Ambrogi F, Zabucchi G, Boracchi P, Biganzoli E, et al. Epithelial-mesenchymal transition, cell polarity and stemnessassociated features in malignant pleural mesothelioma. Cancer Lett 2011; 302; 136-43.
143. Hoevel T, Macek R, Swisshelm K, Kubbies M. Re-expression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids. Int J Cancer 2004; 108: 374-83. (Pubitemid 37549602)
144. Osanai M, Murata M, Nishikiori N, Chiba H, Kojima T, Sawad N. Epigenetic silencing of occludin promotes tumorigenic and metastatic properties of cancer cells via modulations of unique sets of apoptosis-associated genes. Cancer Res 2006; 66: 9125-33. (Pubitemid 44521132)
145. Huang YH, Bao Y, Peng W, Goldberg M, Love K, Bumcrot DA, et al. Claudin-3 gene silencing with siRNA suppresses ovarian tumor growth and metastasis. Proc Natl Acad Sci U S A 2009; 106: 3426-30.
146. Kato-Nakano M, Suzuki M, Kawamoto S, Furuya A, Ohta S, Nakamura K, et al. Characterization and evaluation of the antitumour activity of a dual-targeting monoclonal antibody against claudin-3 and claudin-4. Anticancer Res 2010; 30: 4555-62.
147. Suzuki M, Kato-Nakano M, Kawamoto S, Furuya A, Abe Y, Misaka H, et al. Therapeutic antitumor efficacy of monoclonal antibody against Claudin-4 for pancreatic and ovarian cancers. Cancer Sci 2009; 100: 1623-30.
148. Lamagna C, Hodivala-Dilke KM, Imhof BA, Aurrand-Lions M. Antibody against junctional adhesion molecule-c inhibits angiogenesis and tumor growth. Cancer Res 2005; 65: 5703-10. (Pubitemid 40911173)
149. Saeki R, Kondoh M, Kakutani H, Matsuhisa K, Takahashi A, Suzuki H, et al. A claudin-targeting molecule as an inhibitor of tumor metastasis. J Pharmacol Exp Ther 2010; 334: 576-82.
150. Cocco E, Casagrande F, Bellone S, Richter CE, Bellone M, Todeschini P, et al. Clostridium perfringens enterotoxin carboxy-terminal fragment is a novel tumor-homing peptide for human ovarian cancer. BMC Cancer 2010; 10: 349.
151. Wodarz A, Näthke I. Cell polarity in development and cancer. Nat Cell Biol 2007; 9: 1016-24. (Pubitemid 47342312)
152. Florian MC, Geiger H. Concise review: polarity in stem cells, disease, and aging. Stem Cells 2010; 28: 1623-9.
153. McCaffrey LM, Macara IG. The Par3/aPKC interaction is essential for end bud remodelling and progenitor differentiation during mammary gland morphogenesis. Genes Dev 2009; 23: 1450-60.
154. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The Epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-15. (Pubitemid 351636299)